Boston, MA
Attend our Seminar :
Thursday, June 20 | 12:30pm–1:00pm Beacon Hill Hall, Harbor Level
Christopher Bunker, PhD, MBA, Senior Director, Business Development,
Advanced Cell Diagnostics, Inc., a Bio-Techne brand will be speaking on Biomarker Development with RNAscope™ in situ Hybridization Assay PlatformC8B: Small Molecules for Immuno-Oncology Therapeutic Small Molecules for Immuno-Oncology Therapeutics TARGETING IMMUNO-METABOLISM FOR CANCER
For more information visit ACD @ acdbio.com/science/applications/research-areas/neuroscience
Visit our CAR-T Poster :
Tuesday, June 18-20 | Commonwealth Hall
#103 Preclinical CAR-T Cell Target Safety, Biodistribution, and Tumor Infiltration Analysis Using In Situ Hybridization Technology
Presented by Christopher Bunker
Come see us at ACD Booth # 216
